Castle Biosciences CSTL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $116.73M-2.5% | $119.71M+21.1% | $98.84M-19.6% | $122.95M-62.7% | ||
| $5.59M— | $0-100% | $144.26M+6.3% | $135.68M— | ||
| $43.38M-15.3% | $51.22M+33.7% | $38.3M+63.2% | $23.48M+35.8% | ||
| $10.25M+26.0% | $8.14M+2.4% | $7.94M+99.5% | $3.98M+96.9% | ||
| $7.96M+3.7% | $7.67M+21.9% | $6.29M+1.4% | $6.21M+29.1% | ||
| $361.1M+0.3% | $360.15M+21.8% | $295.64M+1.1% | $292.29M-17.4% | ||
| $97.44M+90.6% | $51.12M+101% | $25.43M+77.7% | $14.32M+50.7% | ||
| $18.3M+42.6% | $12.83M+58.2% | $8.11M+3.4% | $7.85M+158% | ||
| $115.74M+81.0% | $63.96M+90.7% | $33.54M+51.4% | $22.16M+76.7% | ||
| $14.8M+27.7% | $11.58M-5.9% | $12.31M+1.0% | $12.18M+65.0% | ||
| $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M— | ||
| $88.88M-7.0% | $95.54M-10.4% | $106.64M-7.8% | $115.66M+30.1% | ||
| $2.34M+45.3% | $1.61M+680% | $206K-51.9% | $428K-32.6% | ||
| $20M+1,529% | $1.23M-14.7% | $1.44M+29.7% | $1.11M-35.3% | ||
| $0— | $0— | $0— | $0— | ||
| $5.56M+56.3% | $3.56M— | —— | —— | ||
| $578.56M+8.9% | $531.24M+17.2% | $453.34M+1.3% | $447.33M-3.3% | ||
| $18.71M+171% | $6.9M-32.8% | $10.27M+117% | $4.73M+85.8% | ||
| $38.29M+17.6% | $32.56M+12.5% | $28.95M+18.8% | $24.36M+57.3% | ||
| $417K+50.0% | $278K— | $0— | —— | ||
| $1.33M-20.4% | $1.67M+46.4% | $1.14M-36.0% | $1.78M+50.7% | ||
| $102K+1.0% | $101K+42.3% | $71K-52.0% | $148K+41.0% | ||
| $1.1M+83.3% | $600K— | —— | $0— | ||
| $68.68M+39.0% | $49.39M+3.6% | $47.67M+31.9% | $36.13M+45.2% | ||
| $9.64M-1.1% | $9.75M— | $0— | —— | ||
| $25.22M+75.8% | $14.35M+1.2% | $14.17M+22.9% | $11.53M+67.1% | ||
| $416K+1.0% | $412K+329% | $96K-59.7% | $238K+3.9% | ||
| $314K+1.0% | $311K+1,144% | $25K-72.2% | $90K-27.4% | ||
| $107.68M+42.8% | $75.4M+21.5% | $62.07M+28.8% | $48.18M-5.2% | ||
| $0— | $0— | $0— | $0— | ||
| $30K+7.1% | $28K+3.7% | $27K0.0% | $27K+8.0% | ||
| $694.86M+6.0% | $655.7M+7.6% | $609.48M+8.8% | $560.41M+10.9% | ||
| -$224.28M-12.1% | -$200.13M+8.4% | -$218.37M-35.7% | -$160.91M-71.6% | ||
| $267K+16.1% | $230K+69.1% | $136K+136% | -$381K— | ||
| $470.87M+3.3% | $455.84M+16.5% | $391.27M-2.0% | $399.15M-3.1% | ||
| $578.56M+8.9% | $531.24M+17.2% | $453.34M+1.3% | $447.33M-3.3% | ||
| $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | ||
| $171.63M+1.0% | $169.87M+17.8% | $144.26M+6.3% | $135.68M— | ||
| $182.78M+5.4% | $173.42M+20.2% | $144.26M— | —— | ||
| $0— | $0— | $0— | $0— | ||
| $3.77M+207% | $1.23M-14.7% | $1.44M+29.7% | $1.11M-35.3% | ||
| $20M— | —— | —— | —— | ||
| $154.06M+22.4% | $125.88M0.0% | $125.88M0.0% | $125.88M+38.5% | ||
| $99.57M-6.3% | $106.23M-9.5% | $117.34M-7.1% | $126.35M+42.1% | ||
| $0— | $0— | —— | —— | ||
| $1.88M+105% | $918K-22.9% | $1.19M+9.6% | $1.09M-16.9% | ||
| $14.8M+27.7% | $11.58M-5.9% | $12.31M+1.0% | $12.18M+65.0% | ||
| $88.88M-7.0% | $95.54M-10.4% | $106.64M-7.8% | $115.66M+30.1% | ||
| $99.57M-6.3% | $106.23M-9.5% | $117.34M-7.1% | $126.35M+42.1% | ||
| $20M— | —— | —— | —— | ||
| $14.8M+27.7% | $11.58M-5.9% | $12.31M+1.0% | $12.18M+65.0% | ||
| $3.77M+207% | $1.23M-14.7% | $1.44M+29.7% | $1.11M-35.3% | ||
| $97.44M+90.6% | $51.12M+101% | $25.43M+77.7% | $14.32M+50.7% | ||
| $14.8M+27.7% | $11.58M-5.9% | $12.31M+1.0% | $12.18M+65.0% | ||
| $3.77M+207% | $1.23M-14.7% | $1.44M+29.7% | $1.11M-35.3% | ||
| $38.29M+17.6% | $32.56M+12.5% | $28.95M+18.8% | $24.36M+57.3% | ||
| $38.29M+17.6% | $32.56M+12.5% | $28.95M+18.8% | $24.36M+57.3% | ||
| $3.21M+37.4% | $2.34M+11.5% | $2.1M-1.3% | $2.13M+11.5% | ||
| $143K-19.2% | $177K— | —— | —— | ||
| $10.06M— | —— | —— | —— | ||
| $2.13M+175% | $774K+19.1% | $650K+56.6% | $415K— | ||
| $37.02M+40.0% | $26.45M+71.7% | $15.41M+13.7% | $13.55M+63.1% | ||
| $10.2M0.0% | $10.2M— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 29.7M+4.2% | 28.5M+3.9% | 27.4M+3.2% | 26.6M+4.6% | ||
| —— | —— | —— | —— | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | ||
| $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 2.8M-6.9% | 3M-6.8% | 3.2M-6.2% | 3.4M-4.7% | ||
| —— | —— | —— | —— | ||
| $36.53+0.8% | $36.23+2.4% | $35.38+0.8% | $35.11+1.0% | ||
| $28.1M+20.6% | $23.3M+7.4% | $21.7M+19.2% | $18.21M+50.8% | ||
| $2.67M+3.6% | $2.58M-25.8% | $3.48M+90.7% | $1.82M+10.1% | ||
| $3.21M+37.4% | $2.34M+11.5% | $2.1M-1.3% | $2.13M+11.5% | ||
| $0— | $0— | $0— | $0— | ||
| $1M— | $0— | —— | —— | ||
| $1.5M— | $0— | —— | $0-100% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | ||
| $29.69M+4.2% | $28.48M+3.9% | $27.41M+3.2% | $26.55M+4.6% | ||
| $29.69M+4.2% | $28.48M+3.9% | $27.41M+3.2% | $26.55M+4.6% | ||
| $10.2M0.0% | $10.2M— | —— | —— | ||
| $10.06M— | —— | —— | —— | ||
| $143K-19.2% | $177K— | —— | —— | ||
| $0— | $0— | $0— | $0— | ||
| $0— | $0— | —— | —— | ||
| $2.34M+45.3% | $1.61M+680% | $206K-51.9% | $428K-32.6% | ||
| —— | —— | —— | —— | ||
| $924K-24.6% | $1.23M+36.7% | $896K— | —— | ||
| $102K+1.0% | $101K+42.3% | $71K-52.0% | $148K+41.0% | ||
| $65.18M+115% | $30.34M+57.7% | $19.24M+88.2% | $10.22M+422% | ||
| $154.06M+22.4% | $125.88M0.0% | $125.88M0.0% | $125.88M+38.5% | ||
| $0— | $0— | $0— | $0— | ||
| 2%— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $8.94M+11.8% | $7.99M+9.2% | $7.32M+39.1% | $5.26M-7.3% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | ||
| $0— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $2.78M-6.9% | $2.99M-6.8% | $3.21M-6.2% | $3.42M-4.7% | ||
| $36.53+0.8% | $36.23+2.4% | $35.38+0.8% | $35.11+1.0% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Castle Biosciences's total assets?
- Castle Biosciences (CSTL) holds $547.8M in total assets, up 9.2% year over year.
- How much debt does Castle Biosciences have?
- Castle Biosciences carries $36.7M in total debt against $461.4M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does Castle Biosciences have?
- Castle Biosciences holds $63.8M in cash and equivalents.
- Can Castle Biosciences cover its short-term obligations?
- Its current ratio is 6.75 — current assets exceed current liabilities.
- Where does Castle Biosciences's balance sheet data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
